Yazar "Yu, Ming-Lung" için listeleme
-
Asia-Pacific association for study of liver guidelines on management of ascites in liver disease
Singh, Virendra; De, Arka; Mehtani, Rohit; Angeli, Paolo; Maiwall, Rakhi; Satapathy, Sanjaya; Singal, Ashwini K.; Saraya, Anoop; Sharma, B. C.; Eapen, C. E.; Rao, P. N.; Shukla, Akash; Shalimar; Choudhary, Narendra S.; Alcantara-Payawal, Diana; Arora, Vinod; Aithal, Guru; Kulkarni, Anand; Roy, Akash; Shrestha, Ananta; al Mahtab, Mamun; Niriella, Madunil A.; Siam, Tan Soek; Zhang, Chun-Qing; Huei, Lee Guan; Yu, Ming-Lung; Roberts, Stuart K.; Peng, Cheng-Yuan; Chen, Tao; George, Jacob; Wong, Vincent; Yılmaz, Yusuf; Treeprasertsuk, Sombat; Kurniawan, Juferdy; Kim, Seung Up; Younossi, Zobair M.; Sarin, Shiv Kumar (Springer, 2023)The development of ascites is a landmark event in the natural history of cirrhosis. -
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry (TM)
Younossi, Zobair M.; Yu, Ming-Lung; Yılmaz, Yusuf; Alswat, Khalid Aida; Buti, Maria; Fernandez, Marlen Ivon Castellanos; Papatheodoridis, Georgios; Hamid, Saeed S.; El-Kassas, Mohamed; Chan, Wah Kheong; Duseja, Ajay K.; Gordon, Stuart C.; Eguchi, Yuichiro; Isakov, Vasily A.; Roberts, Stuart K.; Fan, Jian-Gao; Singal, Ashwani K.; Romero-Gomez, Manuel; Ahmed, Aijaz; Ong, Janus; Lam, Brian P.; Younossi, Issah; Nader, Fatema; Racila, Andrei; Stepanova, Maria; Alqahtani, Saleh (Wiley, 2023)Chronic hepatitis B (CHB) infection is one of the most common causes of cirrhosis and liver cancer worldwide. Our aim was to assess clinical and patient-reported outcome (PRO) profile of CHB patients from different regions ... -
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease
Younossi, Zobair M.; Alqahtani, Saleh A.; Alswat, Khalid; Yılmaz, Yusuf; Keklikkıran, Çağlayan; Funuyet-Salas, Jesús; Romero-Gómez, Manuel; Fan, Jian-Gao; Zheng, Ming-Hua; El-Kassas, Mohamed; Castera, Laurent; Liu, Chun-Jen; Wai-Sun Wong, Vincent; Zelber-Sagi, Shira; Allen, Alina M.; Lam, Brian; Treeprasertsuk, Sombat; Hameed, Saeed; Takahashi, Hirokazu; Kawaguchi, Takumi; Schattenberg, Jörn M.; Duseja, Ajay; Newsome, Phil N.; Francque, Sven; Spearman, C. Wendy; Castellanos Fernández, Marlen I.; Burra, Patrizia; Roberts, Stuart K.; Chan, Wah-Kheong; Arrese, Marco; Silva, Marcelo; Rinella, Mary; Singal, Ashwani K.; Gordon, Stuart; Fuchs, Michael; Alkhouri, Naim; Cusi, Kenneth; Loomba, Rohit; Ranagan, Jane; Eskridge, Wayne; Kautz, Achim; Ong, Janus P.; Kugelmas, Marcelo; Eguchi, Yuichiro; Diago, Moises; Yu, Ming-Lung; Gerber, Lynn; Fornaresio, Lisa; Nader, Fatema; Henry, Linda; Racila, Andrei; Golabi, Pegah; Stepanova, Maria; Carrieri, Patrizia; Lazarus, Jeffrey V. (Elsevier, 2023)Background & Aims: Patients with fatty liver disease may experience stigma from the disease or comorbidities. In this crosssectional study, we aimed to understand stigma among patients with nonalcoholic fatty liver disease ... -
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
Zhang, Huai; Targher, Giovanni; Byrne, Christopher D.; Kim, Seung Up; Wong, Vincent Wai-Sun; Valenti, Luca; Glickman, Myer; Ponce, Jaime; Mantzoros, Christos S.; Crespo, Javier; Gronbaek, Henning; Yang, Wah; Eslam, Mohammed; Wong, Robert J.; Machado, Mariana Verdelho; Yu, Ming-Lung; Ghanem, Omar M.; Okanoue, Takeshi; Liu, Jun-Feng; Lee, Yong-Ho; Xu, Xiao-Yuan; Pan, Qiuwei; Sui, Meili; Lonardo, Amedeo; Yılmaz, Yusuf; Zhu, Li-Yong; Moreno, Christophe; Miele, Luca; Lupsor-Platon, Monica; Zhao, Lei; LaMasters, Teresa LeAnn; Gish, Robert G.; Nedelcu, Marius; Chan, Wah Kheong; Xia, Ming-Feng; Bril, Fernando; Shi, Jun-Ping; Datz, Christian; Romeo, Stefano; Sun, Jian; Liu, Dan; Sookoian, Silvia; Mao, Yi-Min; Méndez-Sánchez, Nahum; Wang, Xiao-Yan; Pyrsopoulos, Nikolaos T.; Fan, Jian-Gao; Fouad, Yasser; Sun, Dan-Qin; Giannini, Cosimo; Chai, Jin; Xia, Ze-Feng; Jun, Dae Won; Li, Guo-Jing; Treeprasertsuk, Sombat; Li, Ying-Xu; Zhang, Faming; Goh, George Boon-Bee; Furuhashi, Masato; Seto, Wai-Kay; Huang, Hui; Di Sessa, Anna; Li, Qing-Hong; Cholongitas, Evangelos; Zhang, Le; Silveira, Themis Reverbel; Sebastiani, Giada; Adams, Leon A.; Chen, Wei; Qi, Xiaolong; Rankovic, Ivan; De Ledinghen, Victor; Lv, Wen-Jie; Hamaguchi, Masahide; Kassir, Radwan; Müller-Wieland, Dirk; Romero-Gomez, Manuel; Xu, Ying; Xu, Yi-Cong; Chen, Shi-Yao; Kermansaravi, Mohammad; Kuchay, Mohammad Shafi; Lefere, Sander; Parmar, Chetan; Lip, Gregory Y. H.; Liu, Chun-Jen; Åberg, Fredrik; Lau, George; George, Jacob; Sarin, Shiv Kumar; Zhou, Jing-Ya; Zheng, Ming-Hua (Springer, 2024)Background: With the implementation of the 11th edition of the International Classification of Diseases (ICD-11) and the publication of the metabolic dysfunction-associated fatty liver disease (MAFLD) nomenclature in 2020, ... -
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease
Younossi, Zobair M.; AlQahtani, Saleh A.; Funuyet-Salas, Jesús; Romero-Gómez, Manuel; Yılmaz, Yusuf; Keklikkıran, Çağlayan; Alswat, Khalid; Yu, Ming-Lung; Liu, Chun-Jen; Fan, Jian-Gao; Zheng, Ming-Hua; Burra, Patrizia; Francque, Sven M.; Castera, Laurent; Schattenberg, Jörn M.; Newsome, Philip N.; Allen, Alina M.; El-Kassas, Mohamed; Treeprasertsuk, Sombat; Hameed, Saeed; Wai-Sun Wong, Vincent; Zelber-Sagi, Shira; Takahashi, Hirokazu; Kawaguchi, Takumi; Castellanos Fernández, Marlen I.; Duseja, Ajay; Arrese, Marco; Rinella, Mary; Singal, Ashwani K.; Gordon, Stuart C.; Fuchs, Michael; Eskridge, Wayne; Alkhouri, Naim; Cusi, Kenneth; Loomba, Rohit; Ranagan, Jane; Kautz, Achim; Ong, Janus P.; Kugelmas, Marcelo; Eguchi, Yuichiro; Diago, Moises; Gerber, Lynn; Lam, Brian; Fornaresio, Lisa; Nader, Fatema; Spearman, C. Wendy; Roberts, Stuart K.; Chan, Wah-Kheong; Silva, Marcelo; Racila, Andrei; Golabi, Pegah; Ananchuensook, Prooksa; Henry, Linda; Stepanova, Maria; Carrieri, Patrizia; Lazarus, Jeffrey V. (Elsevier, 2024)Background & Aims: Patients with nonalcoholic fatty liver disease (NAFLD)/metabolic dysfunction-associated steatotic liver disease (MASLD) face a multifaceted disease burden which includes impaired health-related quality ... -
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus
Zeng, Xu-Fen; Varady, Krista A.; Wang, Xiang-Dong; Targher, Giovanni; Byrne, Christopher D.; Tayyem, Reema; Latella, Giovanni; Bergheim, Ina; Valenzuela, Rodrigo; George, Jacob; Newberry, Carolyn; Zheng, Ju-Sheng; George, Elena S.; Spearman, C. Wendy; Kontogianni, Meropi D.; Ristic-Medic, Danijela; Peres, Wilza Arantes Ferreira; Depboylu, Gamze Yurtdaş; Yang, Wanshui; Chen, Xu; Rosqvist, Fredrik; Mantzoros, Christos S.; Valenti, Luca; Yki-Järvinen, Hannele; Mosca, Antonella; Sookoian, Silvia; Misra, Anoop; Yılmaz, Yusuf; Kim, Won; Fouad, Yasser; Sebastiani, Giada; Wong, Vincent Wai-Sun; Åberg, Fredrik; Wong, Yu Jun; Zhang, Pianhong; Bermúdez-Silva, Francisco-Javier; Ni, Yan; Lupsor-Platon, Monica; Chan, Wah Kheong; Méndez-Sánchez, Nahum; de Knegt, Robert J.; Alam, Shahinul; Treeprasertsuk, Sombat; Wang, Li; Du, Mulong; Zhang, Tiejun; Yu, Ming-Lung; Zhang, Huijie; Qi, Xingshun; Liu, Xin; Pinyopornpanish, Kanokwan; Fan, Yu-Chen; Niu, Kaijun; Jimenez-Chillaron, Josep C.; Zheng, Ming-Hua (Elsevier, 2024)Metabolic dysfunction-associated fatty liver disease (MAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD), has become the leading cause of chronic liver disease worldwide. Optimal dietary intervention ...
